Alembic Limited announced that Mr. C. P. Buch has completed his second consecutive term of five years as an Independent Director and consequently ceases to be a Director of the Company with effect from end of the day on 31st March, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
109.2 INR | -2.77% | +8.27% | +20.88% |
05-30 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
05-13 | Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+20.88% | 346M | |
+27.53% | 25.67B | |
+13.69% | 24.47B | |
-2.14% | 24.84B | |
-17.76% | 24.33B | |
+2.33% | 19.62B | |
+28.77% | 19.72B | |
-0.88% | 18.77B | |
+40.36% | 17.65B | |
-5.25% | 15.33B |
- Stock Market
- Equities
- ALEMBICLTD Stock
- News Alembic Limited
- Alembic Limited Announces Cessation of C. P. Buch as an Independent Director